Revolution Medicines director gifts 30,000 shares

Revolution Medicines, Inc. director Elizabeth M. Anderson reported two bona fide gifts of common stock totaling 30,000 shares.

Rhea-AI Filing Summary

Revolution Medicines, Inc. director Elizabeth M. Anderson reported two bona fide gifts of common stock totaling 30,000 shares. The gifts, coded as "G" transactions, occurred on March 4, 2026 at a reported price of $0.00 per share, indicating non-cash charitable or personal transfers.

After these transactions, Anderson holds 8,215 shares directly and 26,990 shares indirectly. The indirect holdings include 3,142 restricted stock units and shares held by trusts, including the Irrevocable Deed of Trust of David W. Anderson and Elizabeth M. Anderson and the David W. Anderson 1996 Irrevocable Trust.

Insider Trade Summary

30,000 shares gifted

Gift 3 txns

Insider ANDERSON ELIZABETH M

Role Director

Type	Security	Shares	Price	Value
Gift	Common Stock	15,000	$0.00	$0.00
Gift	Common Stock	15,000	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 8,215 shares (Direct); Common Stock — 41,990 shares (Indirect, See footnote)

Footnotes (3)

1. F1. Includes 3,142 restricted stock units.
2. F2. Held by Irrevocable Deed of Trust of David W. Anderson and Elizabeth M. Anderson.
3. F3. Held by David W. Anderson 1996 Irrevocable Trust.

FAQ

What insider transaction did Elizabeth M. Anderson report at Revolution Medicines (RVMD)?

Elizabeth M. Anderson reported two bona fide gifts of Revolution Medicines common stock totaling 30,000 shares. Both transactions occurred on March 4, 2026, were coded as gifts, and carried a reported price of $0.00 per share, reflecting non-cash transfers.

How many Revolution Medicines (RVMD) shares does Elizabeth M. Anderson own after the reported transactions?

After the reported gifts, Elizabeth M. Anderson holds 8,215 Revolution Medicines shares directly and 26,990 shares indirectly. The indirect position includes 3,142 restricted stock units and additional shares held through specified trusts associated with the Anderson family.

Were the reported Revolution Medicines (RVMD) insider transactions open-market sales or purchases?

The reported transactions were not open-market sales or purchases; they were bona fide gifts. Both entries are coded “G” for gift, with a transaction price of $0.00 per share, indicating transfers without consideration rather than market trading activity.

How are Elizabeth M. Anderson’s indirect Revolution Medicines (RVMD) holdings structured?

Her indirect holdings total 26,990 shares of Revolution Medicines common stock. These include 3,142 restricted stock units and shares held by the Irrevocable Deed of Trust of David W. Anderson and Elizabeth M. Anderson and the David W. Anderson 1996 Irrevocable Trust.

What does the Form 4 gift code "G" mean for Revolution Medicines (RVMD) director transactions?

Code “G” on Form 4 designates a bona fide gift of securities, not a sale or purchase. For Revolution Medicines, Elizabeth M. Anderson used this code to report transferring 30,000 common shares at $0.00 per share on March 4, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 03/06/2026 - 06:20 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

ANDERSON ELIZABETH M

(Last) (First) (Middle)

C/O REVOLUTION MEDICINES, INC.

700 SAGINAW DRIVE

(Street)

REDWOOD CITY CA 94063

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Revolution Medicines, Inc. [ RVMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/04/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/04/2026		G		15,000	D	$0	8,215(1)	D
Common Stock	03/04/2026		G		15,000	A	$0	15,000	I	See footnote(2)
Common Stock								26,990	I	See footnote(3)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Includes 3,142 restricted stock units.

2. Held by Irrevocable Deed of Trust of David W. Anderson and Elizabeth M. Anderson.

3. Held by David W. Anderson 1996 Irrevocable Trust.

	/s/ Jack Anders, as Attorney-in-fact for Elizabeth M. Anderson	03/06/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.